Malta K, Palazzi C, Neves V, Aguiar Y, Silva T, Melo R
Microorganisms. 2022; 10(10).
PMID: 36296298
PMC: 9607553.
DOI: 10.3390/microorganisms10102022.
Ariyaratne A, Finney C
Infect Immun. 2019; 87(10).
PMID: 31285249
PMC: 6759305.
DOI: 10.1128/IAI.00127-19.
Williams D, Asahi H, Botkin D, Stadecker M
Infect Immun. 2001; 69(2):1134-41.
PMID: 11160011
PMC: 97995.
DOI: 10.1128/IAI.69.2.1134-1141.2001.
Brunet L, Sabin E, CHEEVER A, Kopf M, Pearce E
Infect Immun. 1999; 67(6):3014-8.
PMID: 10338513
PMC: 96614.
DOI: 10.1128/IAI.67.6.3014-3018.1999.
Olds G, Mahmoud A
J Clin Invest. 1980; 66(6):1191-9.
PMID: 7440710
PMC: 371603.
DOI: 10.1172/JCI109970.
Host granulomatous response in schistosomiasis mansoni. Antibody and cell-mediated damage of parasite eggs in vitro.
de Brito P, Kazura J, Mahmoud A
J Clin Invest. 1984; 74(5):1715-23.
PMID: 6542110
PMC: 425350.
DOI: 10.1172/JCI111589.
Unisexual murine schistosomiasis: portal hepatitis in subacute infections.
Baki C, Grimaud J
Experientia. 1985; 41(11):1423-6.
PMID: 3933998
DOI: 10.1007/BF01950016.
Role of granulocyte oxygen products in damage of Schistosoma mansoni eggs in vitro.
Kazura J, de Brito P, Rabbege J, Aikawa M
J Clin Invest. 1985; 75(4):1297-307.
PMID: 2985656
PMC: 425459.
DOI: 10.1172/JCI111830.
Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni.
Sher A, Coffman R, Hieny S, Scott P, CHEEVER A
Proc Natl Acad Sci U S A. 1990; 87(1):61-5.
PMID: 2104985
PMC: 53199.
DOI: 10.1073/pnas.87.1.61.
Development of the granulomatous response in murine toxocariasis. Initial events.
Kayes S, Oaks J
Am J Pathol. 1978; 93(2):277-94.
PMID: 717533
PMC: 2018380.
